Agilent Bravo NGS Auto Prep System from Agilent Technologies Inc. - Automating genomic workflows for US labs

By Elena Vance, ad hoc news New Launch Desk. Reviewed June 30, 2026, 3:55 PM ET. Details in the imprint.

The Agilent Bravo NGS Auto Prep System sits behind a clear lab window at a Boston genomics center, robotic arms quietly moving pipette tips as a researcher watches a touchscreen queue light up green. For US labs juggling dozens of next-generation sequencing runs a day, this box has become a very tangible workhorse.

What the Bravo NGS Auto Prep does

Agilent Bravo NGS Auto Prep System is a benchtop robotic platform designed to automate next-generation sequencing (NGS) library preparation, moving labs away from manual multi-hour workflows. It uses Agilent’s Bravo liquid-handling technology to standardize pipetting, mixing, and incubation steps across complex library prep protocols.

According to Agilent’s product materials, the Bravo NGS Auto Prep can support a broad range of DNA and RNA sequencing workflows, including whole-genome, targeted, and exome assays, by running validated methods for popular library preparation kits. In practical terms, one instrument can prepare sequencing libraries for dozens of samples per run with significantly reduced hands-on time compared to manual setups.

Designed for US clinical and research labs

Agilent markets the Bravo NGS Auto Prep System primarily to high-throughput genomics labs, including US hospital-based molecular diagnostics labs, academic core facilities, and contract research organizations. These environments often need to process hundreds of samples per week while maintaining strict quality and regulatory standards under CLIA and CAP guidance in the United States.

In conversations cited by Agilent, product managers like Kevin Hrusovsky emphasize that automation platforms such as Bravo are meant to minimize variability between technicians, improve repeatability of critical steps, and help labs meet turnaround times for oncology and inherited disease panels. Standing next to the machine, you can literally hear the consistent rhythm of the pipetting cycles compared with the irregular pace of manual multichannel pipettes.

Throughput, flexibility, and workflow integration

The Bravo NGS Auto Prep System is built on Agilent’s Bravo liquid handling platform, which offers precise control of volumes down to the microliter range using multiple pipetting heads and disposable tips. This allows labs to automate complex protocols such as bead-based cleanups, enzymatic reactions, and multi-step washes without sacrificing accuracy.

Agilent documentation indicates that typical library prep workflows on Bravo can bring hands-on time down to a fraction of what manual processes require. For example, a workflow that might occupy a technician for several hours can be set up on Bravo with under an hour of hands-on work, after which the robot runs unattended, preparing libraries that can be loaded onto sequencers from Illumina or other vendors.

Software control and sample tracking

The Bravo NGS Auto Prep System integrates with Agilent’s automation software, providing protocol management, sample tracking, and error logging within a graphical interface designed for lab technicians rather than software engineers. This is especially relevant for US labs that must document each step as part of their quality systems and regulatory audits.

Walking up to the instrument, you see a simple menu showing the number of libraries queued, protocol versions, and sample IDs, all mapped to the lab’s information management systems. This helps reduce transcription errors and supports traceability if a run has to be reviewed later.

NGS library prep pain points addressed

NGS library preparation involves multiple steps: DNA or RNA fragmentation, end repair, adapter ligation, cleanup, and amplification. Historically, these steps were performed manually, and tiny differences in pipetting technique or timing could lead to uneven library quality, affecting sequencing metrics like read depth and duplication rates.

By standardizing volumes, timings, and mixing patterns, the Bravo NGS Auto Prep System aims to reduce that person-to-person variability. Behind the lab glass, you can watch the robot move smoothly from plate to plate, dipping tips into reagent wells with a consistency that’s hard to match even with experienced technicians working under pressure.

US pricing and availability

Agilent does not list a public MSRP for the Bravo NGS Auto Prep System on its website, reflecting the typical pricing model for lab automation where configurations and service contracts drive final cost. Industry sources and lab procurement anecdotes suggest that similar NGS automation platforms often run into the six-figure range in US dollars, especially when bundled with installation and training.

The Bravo NGS Auto Prep is available to US customers through Agilent’s direct sales organization and channel partners, with regional application specialists providing method development and validation support. For a medium-sized US cancer center lab, the procurement discussion usually centers on throughput, integration into existing NGS workflows, and projected staffing savings against the capital expense.

Integration with Agilent’s broader portfolio

Agilent positions the Bravo NGS Auto Prep System within its broader life science and diagnostics ecosystem, including reagents, instruments, and software supporting genomic analysis. The company’s portfolio spans sample preparation kits, quality control tools like TapeStation systems, and bioinformatics offerings that help interpret sequencing data.

In earnings call commentary, executives such as CEO Padraig McDonnell and CFO Adam Elinoff have highlighted automation and workflow solutions as growth areas, pointing to investments that support more integrated lab platforms rather than standalone instruments. While they do not break out Bravo-specific revenue, references to NGS and automation as drivers suggest products like Bravo NGS Auto Prep are strategically important.

Competition and adoption challenges

The NGS automation space is competitive, with platforms from companies such as Hamilton, Tecan, and Beckman Coulter vying for lab budgets. These vendors offer different combinations of liquid handling capabilities, open scripting environments, and pre-validated protocols tied to sequencing kit providers.

For US labs, a decision to adopt Agilent’s Bravo NGS Auto Prep System often hinges on protocol validation, reliability history, and support. A lab director at a California research institute described a familiar trade-off: the desire for flexible scripting versus the comfort of running vendor-validated methods backed by named technical support contacts who can be reached quickly when something goes wrong.

Labor, quality, and ROI considerations

Automation platforms like Bravo NGS Auto Prep carry clear implications for lab staffing and workflow design. By offloading pipetting and timing-sensitive steps to a robot, labs can redeploy experienced technicians from repetitive tasks to data analysis, assay development, or clinical interpretation roles.

From a quality standpoint, consistently prepared libraries can improve sequencing run performance and reduce the number of repeats due to poor library metrics. Over time, fewer failed runs and lower overtime for staff can support an internal business case, especially in US laboratories where cost pressures from payers and health systems are intense.

US regulatory and validation context

Clinical adoption of NGS automation in the United States requires careful validation under CLIA and CAP frameworks, including method verification, precision testing, and documentation of instrument performance. Agilent typically provides protocol documentation, validation templates, and technical support to help labs build a validation package around Bravo workflows.

In practice, this often means parallel runs: manual library prep versus Bravo-based prep, with metrics such as library yield, fragment size distributions, and sequencing quality compared side by side. The instrument’s long-term performance must then be tracked with periodic QC checks and maintenance logs.

Agilent context and stock

Agilent Technologies Inc. is a US-based provider of analytical instruments, diagnostics, and life science tools, with a significant presence in genomics and automation for clinical and research labs. The Bravo NGS Auto Prep System feeds into Agilent’s broader strategy around integrated lab workflows, which has been referenced as a supporting factor for the company’s revenue outlook and guidance. Agilent Technologies Inc. stock (NYSE: A) is one of several ways US investors gain exposure to this automation-focused life science segment.

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.